Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0000899243-21-034635)

Filing Details

Accession Number:
0000899243-21-034635
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2021-08-31 19:52:56
Reporting Period:
2021-08-26
Accepted Time:
2021-08-31 19:52:56
Original Submission Date:
2021-08-30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1422142 Aadi Bioscience Inc. AADI Pharmaceutical Preparations (2834) 611547850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1602474 Anupam Dalal C/O Aadi Bioscience, Inc.
17383 Sunset Boulevard, Suite A250
Pacific Palisades CA 90272		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-26 1,529,402 $13.08 1,529,402 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Footnotes
  1. Consists of (i) 1,284,698 shares held by Acuta Capital Fund, LP ("Acuta Capital") and (ii) 244,704 shares held by Acuta Opportunity Fund, LP. ("Acuta Opportunity Fund"). Acuta Capital Partners, LLC ("Acuta Partners") is the general partner of each of Acuta Capital and Acuta Opportunity Fund. The Reporting Person is the Chief Investment Officer and Managing Member of Acuta Partners. The Reporting Person has voting and investment authority over all of the shares held by each of Acuta Capital and Acuta Opportunity Fund. Each of Acuta Partners and the Reporting Person disclaim beneficial ownership of the shares of common stock held by each of Acuta Capital and Acuta Opportunity Fund except to the extent of their pecuniary interest therein.
  2. This amendment is filed to correct footnote (1) included in the Form 4 filed August 30, 2021.